Role of phosphorylation in the conformation of τ peptides implicated in Alzheimer's disease

被引:71
|
作者
Daly, NL
Hoffmann, R
Otvos, L
Craik, DJ [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia
[2] Univ Dusseldorf, BMFZ, D-40001 Dusseldorf, Germany
[3] Wistar Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1021/bi0004807
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of peptides corresponding to isolated regions of Tau (tau) protein have been synthesized and their conformations determined by H-1 NMR spectroscopy. Immunodominant peptides corresponding to tau(224-240) and a bisphosphorylated derivative in which a single Thr and a single Ser are phosphorylated at positions 231 and 235 respectively, and which are recognized by an Alzheimer's disease-specific monoclonal antibody, were the main focus of the study. The nonphosphorylated peptide adopts essentially a random coil conformation in aqueous solution, but becomes slightly more ordered into P-type structure as the hydrophobicity of the solvent is increased by adding up to 50% trifluoroethanol (TFE). Similar trends are observed for the bisphosphorylated peptide, with a somewhat stronger tendency to form an extended structure, There is tentative NMR evidence for a small population of species containing a turn at residues 229-231 in the phosphorylated peptide, and this is strongly supported by CD spectroscopy. A proposal that the selection of a bioactive conformation from a disordered solution ensemble may be an important step (in either tubulin binding or in the formation of PHF) is supported by kinetic data on Pro isomerization. A recent study showed that Thr231 phosphorylation affected the rate of prolyl isomerization and abolished tubulin binding. This binding was restored by the action of the prolyl isomerase Pin1. In the current study, we find evidence for the existence of both trans and cis forms of tau peptides in solution but no difference in the equilibrium distribution of cis-trans isomers upon phosphorylation. Increasing hydrophobicity decreases the prevalence of cis forms and increases the major trans conformation of each of the prolines present in these molecules. We also synthesized mutant peptides containing Tyr substitutions preceding the Pro residues and found that phosphorylation of Tyr appears to have an effect on the equilibrium ratio of cis-trans isomerization and decreases the cis content.
引用
收藏
页码:9039 / 9046
页数:8
相关论文
共 50 条
  • [31] Abnormality of cytoskeletons and their phosphorylation in Alzheimer's disease
    Nakamura, Y
    Takeda, M
    SEIKAGAKU, 1996, 68 (02): : 133 - 137
  • [32] Oxidative phosphorylation defects and Alzheimer's disease
    Shoffner, JM
    NEUROGENETICS, 1997, 1 (01) : 13 - 19
  • [33] The phosphorylation cascade hypothesis of Alzheimer’s disease
    Gunnar Brinkmalm
    Henrik Zetterberg
    Nature Aging, 2021, 1 : 498 - 499
  • [34] Regulation of tau phosphorylation in Alzheimer's disease
    Lee, VMY
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 107 - 113
  • [35] Oxidative phosphorylation defects and Alzheimer's disease
    John M. Shoffner
    Neurogenetics, 1997, 1 : 13 - 19
  • [36] METAL IONS AND THE CONFORMATION OF PEPTIDES FORMING AMYLOID DEPOSITS IN ALZHEIMER AND PRION DISEASE
    Menestrina, G.
    Comai, M.
    Potrich, C.
    Dalla Serra, M.
    Guella, G.
    Frassanito, R.
    Meneghini, C.
    Mobilio, S.
    Morante, S.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C245 - C245
  • [37] Key Peptides and Proteins in Alzheimer's Disease
    Penke, Botond
    Bogar, Ferenc
    Paragi, Gabor
    Gera, Janos
    Fulop, Livia
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (06) : 577 - 599
  • [38] Peptides as drug targets for Alzheimer's disease
    Gozes, I
    Spier, AD
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344
  • [39] Selecting Multitarget Peptides for Alzheimer's Disease
    Kasus-Jacobi, Anne
    Washburn, Jennifer L.
    Laurence, Riley B.
    Pereira, H. Anne
    BIOMOLECULES, 2022, 12 (10)
  • [40] Peptides as Potential Therapeutics for Alzheimer's Disease
    Ribaric, Samo
    MOLECULES, 2018, 23 (02):